APSR2026-958

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-082
P101
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1239384-46904-APSR26PosterSynovialSarcoma.pdf_430475.pdf
Format: PDF Only
08. Lung Cancer
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Siok Geik Tan * Sarikei Hospital Medical Department Sarikei Malaysia
Chee Jui Goh - Sarikei Hospital Medical Department Sarikei Malaysia
Xiu Xin Teng - Sarikei Hospital Medical Department Sarikei Malaysia
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Siok Geik
Tan
siokgeiktan97@gmail.com
+601110600719
Under 30
Malaysia
Case Report
Primary synovial sarcoma of the lung – when rare means lethal
Maximum 25 words
Abstract Content
 
 
 
 
Primary pulmonary synovial sarcomas are exceedingly rare, accounting for approximately 0.5% of all primary lung malignancies (Dole & Barthwal, 2024).
We report a case of a 21-year-old man with a 6-year history of vaping, who presented with a one-month history of productive cough, shortness of breath, pleuritic chest pain, and reduced exercise tolerance. Subsequent clinical and radiological examination confirmed a massive right pleural effusion with an underlying lung mass. Diagnostic pleural aspiration showed exudative fluid, negative for tuberculosis and no malignant cells. CT imaging of the thorax, abdomen, and pelvis demonstrated a large right upper lobe mass measuring 11.7 × 8.8 × 14.3 cm, with pulmonary metastases, mediastinal lymphadenopathy, and thrombosis of the superior vena cava extending into the right internal jugular vein. CT-guided biopsy of the right lung mass showed tumour cells of ovoid to spindled and overlapped vesicular nuclei and inconspicuous nucleoli. Based on the above results along with immunohistochemistry staining, a diagnosis of primary synovial sarcoma of the lung was made. The tumour was deemed inoperable, and the patient was started on chemotherapy with doxorubicin and ifosfamide, along with apixaban for venous thrombosis. The patient ultimately succumbed from pneumonia and recurrent anaemia after 1 cycle of chemotherapy. The interval from presentation to death was approximately two months.
This rare tumour predominantly affects young adults with a mean age of 23 years old with male predominance. Diagnosis requires integration of clinical, radiological, pathological, and immunohistochemical findings (Roy et al., 2012). Management options include surgery, chemotherapy, and targeted therapies, depending on disease stage. Primary pulmonary synovial sarcoma carries a poor prognosis. Adverse factors include tumor size >5 cm, male sex, age >20 years, extensive necrosis, high mitotic activity (>10/10 HPF), neurovascular invasion, and the SYT-SSX1 variant. (Gupta, A. et al, 2018)
 
 
Yes
No
 
JPG or JPEG or PNG format ONLY
 
maximum 3 keywords and no abbreviations, separated by commas
 
294